JP2023509373A5 - - Google Patents

Info

Publication number
JP2023509373A5
JP2023509373A5 JP2022537428A JP2022537428A JP2023509373A5 JP 2023509373 A5 JP2023509373 A5 JP 2023509373A5 JP 2022537428 A JP2022537428 A JP 2022537428A JP 2022537428 A JP2022537428 A JP 2022537428A JP 2023509373 A5 JP2023509373 A5 JP 2023509373A5
Authority
JP
Japan
Prior art keywords
seq
sequence
antibody
variable region
chain variable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022537428A
Other languages
English (en)
Japanese (ja)
Other versions
JP7758672B2 (ja
JP2023509373A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/060539 external-priority patent/WO2021126435A1/en
Publication of JP2023509373A publication Critical patent/JP2023509373A/ja
Publication of JP2023509373A5 publication Critical patent/JP2023509373A5/ja
Application granted granted Critical
Publication of JP7758672B2 publication Critical patent/JP7758672B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022537428A 2019-12-20 2020-11-13 抗インターロイキン-23 p19抗体およびそれの使用方法 Active JP7758672B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962951231P 2019-12-20 2019-12-20
US62/951,231 2019-12-20
PCT/US2020/060539 WO2021126435A1 (en) 2019-12-20 2020-11-13 Anti-interleukin-23 p19 antibodies and methods of use thereof

Publications (3)

Publication Number Publication Date
JP2023509373A JP2023509373A (ja) 2023-03-08
JP2023509373A5 true JP2023509373A5 (https=) 2023-11-20
JP7758672B2 JP7758672B2 (ja) 2025-10-22

Family

ID=73790243

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022537428A Active JP7758672B2 (ja) 2019-12-20 2020-11-13 抗インターロイキン-23 p19抗体およびそれの使用方法

Country Status (8)

Country Link
US (2) US11396541B2 (https=)
EP (1) EP4077378A1 (https=)
JP (1) JP7758672B2 (https=)
KR (1) KR20220143005A (https=)
CN (1) CN115135671B (https=)
AU (1) AU2020409124A1 (https=)
CA (1) CA3164996A1 (https=)
WO (1) WO2021126435A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4395823A4 (en) * 2021-09-03 2025-07-16 Novarock Biotherapeutics Ltd BISPECIFIC BINDING PROTEINS THAT BIND TO CD137 AND A TUMOR-ASSOCIATED ANTIGEN
CN115785267B (zh) * 2021-09-10 2023-12-15 三优生物医药(上海)有限公司 一种靶向IL-23p19的抗体或其抗原结合片段及其应用
CN121843958A (zh) * 2023-08-11 2026-04-10 信达生物医药科技(杭州)有限公司 既往接受生物制剂治疗斑块状银屑病的受试者转用抗IL23p19抗体治疗斑块状银屑病的方法
CN120025436B (zh) * 2025-01-17 2025-11-18 暨南大学 一种靶向白细胞介素-23 p19亚基的单克隆抗体及其应用

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4741900A (en) 1982-11-16 1988-05-03 Cytogen Corporation Antibody-metal ion complexes
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4737456A (en) 1985-05-09 1988-04-12 Syntex (U.S.A.) Inc. Reducing interference in ligand-receptor binding assays
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
IL162181A (en) 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same
FR2646437B1 (fr) 1989-04-28 1991-08-30 Transgene Sa Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant
US6075181A (en) 1990-01-12 2000-06-13 Abgenix, Inc. Human antibodies derived from immunized xenomice
US6150584A (en) 1990-01-12 2000-11-21 Abgenix, Inc. Human antibodies derived from immunized xenomice
US5264618A (en) 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
WO1991017424A1 (en) 1990-05-03 1991-11-14 Vical, Inc. Intracellular delivery of biologically active substances by means of self-assembling lipid complexes
ATE158021T1 (de) 1990-08-29 1997-09-15 Genpharm Int Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper
US6300129B1 (en) 1990-08-29 2001-10-09 Genpharm International Transgenic non-human animals for producing heterologous antibodies
WO1992022645A1 (en) 1991-06-14 1992-12-23 Genpharm International, Inc. Transgenic immunodeficient non-human animals
CA2113113A1 (en) 1991-07-08 1993-01-21 Simon W. Kantor Thermotropic liquid crystal segmented block copolymer
JPH08509612A (ja) 1993-04-26 1996-10-15 ジェンファーム インターナショナル インコーポレイテッド 異種抗体を産生することができるトランスジェニック非ヒト動物
ZA986596B (en) 1997-07-25 1999-02-08 Schering Corp Mammalian cytokine related reagents
MXPA02000962A (es) 1999-07-29 2002-07-02 Medarex Inc Anticuerpos monoclonales humanos para her2/neu.
US6902734B2 (en) 2000-08-07 2005-06-07 Centocor, Inc. Anti-IL-12 antibodies and compositions thereof
SI2452694T1 (sl) 2005-06-30 2019-05-31 Janssen Biotech, Inc. Protitelesa proti-IL-23, sestavki in postopki uporabe
US7747677B2 (en) 2005-08-03 2010-06-29 Bea Systems, Inc. System and method for control tree optimization
PT1931710T (pt) 2005-08-31 2017-03-28 Merck Sharp & Dohme Anticorpos anti-il-23 manipulados
HUE034269T2 (en) * 2005-12-29 2018-02-28 Janssen Biotech Inc Human anti-IL-23 antibodies, preparations, methods and applications
US7790862B2 (en) 2006-06-13 2010-09-07 Zymogenetics, Inc. IL-17 and IL-23 antagonists and methods of using the same
TWI426918B (zh) * 2007-02-12 2014-02-21 Merck Sharp & Dohme Il-23拮抗劑於治療感染之用途
ES2708988T3 (es) 2007-02-23 2019-04-12 Merck Sharp & Dohme Anticuerpos anti-IL-23p19 obtenidos por ingeniería genética
JP2010518858A (ja) 2007-02-23 2010-06-03 シェーリング コーポレイション 操作された抗−il−23p19抗体
JOP20080381B1 (ar) * 2007-08-23 2023-03-28 Amgen Inc بروتينات مرتبطة بمولدات مضادات تتفاعل مع بروبروتين كونفيرتاز سيتيليزين ككسين من النوع 9 (pcsk9)
AR068723A1 (es) 2007-10-05 2009-12-02 Glaxo Group Ltd Proteina que se une a antigenos que se une a il-23 humana y sus usos
WO2009082624A2 (en) 2007-12-10 2009-07-02 Zymogenetics, Inc. Antagonists of il-17a, il-17f, and il-23 and methods of using the same
JO3244B1 (ar) 2009-10-26 2018-03-08 Amgen Inc بروتينات ربط مستضادات il – 23 البشرية
GB201013975D0 (en) * 2010-08-20 2010-10-06 Imp Innovations Ltd Method of treating desease
MX2019000046A (es) 2010-11-04 2023-10-05 Boehringer Ingelheim Int Anticuerpos anti-il-23.
CN102469482A (zh) 2010-11-12 2012-05-23 中兴通讯股份有限公司 一种广播控制信道信息倒换方法及系统
US20140283153A1 (en) 2011-10-28 2014-09-18 Trianni, Inc. Transgenic animals and methods of use
PL3326649T3 (pl) 2012-05-03 2022-04-25 Boehringer Ingelheim International Gmbh Przeciwciała anty-il-23p19
UA117466C2 (uk) * 2012-12-13 2018-08-10 Мерк Шарп Енд Доме Корп. СТАБІЛЬНИЙ СКЛАД У ВИГЛЯДІ РОЗЧИНУ АНТИТІЛА ДО IL-23p19
AR094877A1 (es) 2013-03-08 2015-09-02 Lilly Co Eli Anticuerpos que se unen a il-23
AR102417A1 (es) * 2014-11-05 2017-03-01 Lilly Co Eli Anticuerpos biespecíficos anti-tnf- / anti-il-23
JP2018525007A (ja) 2015-08-24 2018-09-06 トリアンニ インコーポレイテッドTrianni,Inc. 免疫グロブリンの産生増強
CN108290058B (zh) 2015-09-17 2023-05-16 美国安进公司 使用il23途径生物标志物预测il23拮抗剂的临床应答
EP4414484A3 (en) 2016-02-04 2025-01-15 Trianni, Inc. Enhanced production of immunoglobulins
TW202535466A (zh) 2019-09-09 2025-09-16 德商百靈佳殷格翰國際股份有限公司 抗-il-23p19抗體調配物

Similar Documents

Publication Publication Date Title
JP2023540526A5 (https=)
JP2024109678A5 (https=)
JP2023509373A5 (https=)
JP2023002562A5 (https=)
JP2023504572A5 (https=)
JP2021514664A5 (https=)
JP2022512132A5 (https=)
JP2024522360A5 (https=)
IL276830B2 (en) Anti-claudin 18.2 antibodies and uses thereof
JP2021521843A5 (https=)
JP2015163068A5 (https=)
JP2020525032A5 (https=)
JP2023526774A5 (https=)
JP2020522280A5 (https=)
JP2020522281A5 (https=)
CN112513094A (zh) 结合人her2的抗体、其制备方法和用途
JP2024541680A5 (https=)
JP2024518776A5 (https=)
JP2024024114A5 (https=)
JP2023506465A5 (https=)
JP2025508066A5 (https=)
JP2020522488A5 (https=)
JP2023510982A5 (https=)
JP2020533965A5 (https=)
JP2024540148A5 (https=)